Gene · 4036
Papers3,623
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,623
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium. | Clin Pharmacol Ther | 2022 | 35488474 | PubTator, text mining | PubMed |
| Hedgehog signaling and its molecular perspective with cholesterol: a comprehensive review. | Cell Mol Life Sci | 2022 | 35486193 | PubTator, text mining | PubMed |
| Healthy lifestyle counteracts the risk effect of genetic factors on incident gout: a large population-based longitudinal study. | BMC Med | 2022 | 35484537 | PubTator, text mining | PubMed |
| Regulatory Role of Host MicroRNAs in Flaviviruses Infection. | Front Microbiol | 2022 | 35479613 | PubTator, text mining | PubMed |
| Angiopoietin2-mediated caveolin1 phosphorylation regulating transcytosis of renal tubular epithelial cell contributes to the occurrence of albuminuria under high glucose exposure. | J Transl Med | 2022 | 35468852 | PubTator, text mining | PubMed |
| Connecting the Dots Between Hypercholesterolemia and Alzheimer's Disease: A Potential Mechanism Based on 27-Hydroxycholesterol. | Front Neurosci | 2022 | 35464321 | PubTator, text mining | PubMed |
| Comprehensive Bioinformatics Analysis of Gasdermin Family of Glioma. | Comput Intell Neurosci | 2022 | 35463276 | PubTator, text mining | PubMed |
| Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation. | Pharmaceutics | 2022 | 35456562 | PubTator, text mining | PubMed |
| Novel Protein-Protein Interactions Highlighting the Crosstalk between Hypoplastic Left Heart Syndrome, Ciliopathies and Neurodevelopmental Delays. | Genes (Basel) | 2022 | 35456433 | PubTator, text mining | PubMed |
| Human iPSC-Derived Renal Cells Change Their Immunogenic Properties during Maturation: Implications for Regenerative Therapies. | Cells | 2022 | 35456007 | PubTator, text mining | PubMed |
| Beyond the Cardiorenal Syndrome: Pathophysiological Approaches and Biomarkers for Renal and Cardiac Crosstalk. | Diagnostics (Basel) | 2022 | 35453821 | PubTator, text mining | PubMed |
| Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure. | Biomedicines | 2022 | 35453565 | PubTator, text mining | PubMed |
| Assessing the Role of Ependymal and Vascular Cells as Sources of Extracellular Cues Regulating the Mouse Ventricular-Subventricular Zone Neurogenic Niche. | Front Cell Dev Biol | 2022 | 35450289 | PubTator, text mining | PubMed |
| Selective ferroptosis vulnerability due to familial Alzheimer's disease presenilin mutations. | Cell Death Differ | 2022 | 35449212 | PubTator, text mining | PubMed |
| Whole Genome Sequencing in Hypoplastic Left Heart Syndrome. | J Cardiovasc Dev Dis | 2022 | 35448093 | PubTator, text mining | PubMed |
| Immune Landscape in PTEN-Related Glioma Microenvironment: A Bioinformatic Analysis. | Brain Sci | 2022 | 35448032 | PubTator, text mining | PubMed |
| Renal hypoxia-HIF-PHD-EPO signaling in transition metal nephrotoxicity: friend or foe? | Arch Toxicol | 2022 | 35445830 | PubTator, text mining | PubMed |
| The genomic landscape of pediatric renal cell carcinomas. | iScience | 2022 | 35445187 | PubTator, text mining | PubMed |
| Systemic Sclerosis (SSc) After COVID-19: A Case Report. | Cureus | 2022 | 35444873 | PubTator, text mining | PubMed |
| Association between the Expression Levels of MicroRNA-101, -103, and -29a with Autotaxin and Lysophosphatidic Acid Receptor 2 Expression in Gastric Cancer Patients. | J Oncol | 2022 | 35444696 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4036/papers?page=43